CapitalBio® BioelectronSeq 4000 System (abbreviation: BES 4000) is a next-generation sequencing system developed and produced by the cooperation between CapitalBio Corporation and Thermo Fisher Scientific Inc. in China. The system using semiconductor sequencing technology, combined with clinical testing kits and automated data analysis & management software, is suitable to be deployed and placed in clinical